Breaking News

Research Point Global and WuXi CDS to Rebrand as WuXi Clinical

The newly combined CRO specializes in collaborative partnering for global clinical trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The recently merged Research Point Global (RPG) and WuXi Clinical Development Services (CDS) are to rebrand as WuXi Clinical.   The newly combined contract research organization (CRO) employs roughly 1000 clinical research specialists across 20 global locations with two main hubs in the U.S. and China. WuXi Clinical will continue to focus on the expanding opportunities across small to mid-tier clients,  offering tailored, customer-centric, full-service global clinical trial management. However...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters